Evidence map›Paper›PMID 28210747›Full record

ReviewSingapore medical journal2018

Extent of field change in colorectal cancers with BRAF mutation.

Aaron Poh, Heidi Sian Ying Chang, Kok Yang Tan, Xin Xiu Sam, Avery Khoo, Shoa Nian Choo, Min En Nga, Wei Keat Wan

Open access · diamondAbstract readReview
In one paragraph

Review in Singapore medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aaron PohDepartment of General Surgery, Khoo Teck Puat Hospital, Singapore.
Heidi Sian Ying ChangUniversity Surgical Cluster, National University Hospital, Singapore.
Kok Yang TanDepartment of General Surgery, Khoo Teck Puat Hospital, Singapore.
Xin Xiu SamHistopathology Translational Research Group, Department of Pathology, Singapore General Hospital, Singapore.
Avery KhooHistopathology Translational Research Group, Department of Pathology, Singapore General Hospital, Singapore.
Shoa Nian ChooDepartment of Pathology, National University Hospital, Singapore.
Min En NgaDepartment of Pathology, National University Hospital, Singapore.
Wei Keat WanDepartment of Pathology, Singapore General Hospital, Singapore.
National University Hospital · SGKhoo Teck Puat Hospital · SGSingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSporadic colorectal cancers with BRAF mutations constitute two distinct subgroups of colorectal cancers. Recent studies have linked the presence of the BRAF mutation to a familial inheritance pattern. This was a proof-of-concept study that aimed to examine: (a) the extent of field change in sporadic colorectal cancers with BRAF mutation; and (b) the extent of resection margins required and the pattern of DNA mismatch repair protein loss in these tumours.

methodsEight microsatellite instability-high tumours with positive BRAF mutation from an existing histopathological database were selected for BRAF mutation and mismatch repair protein analysis.

resultsAll the resection margins were negative for BRAF mutation. Three tumours had loss of MLH1 and PMS2 expressions, and five tumours had no protein loss. Six peritumoral tissues were negative and one was positive for BRAF mutation.

conclusionThe results suggest that any early field change effect is restricted to the immediate vicinity of the tumour and is not a pan-colonic phenomenon. Current guidelines on resection margins are adequate for BRAF mutation-positive colorectal cancers. Any suggestion of a hereditary link to these tumours is likely not related to germline BRAF gene mutations. The pattern of protein loss reinforces previous findings for the two subgroups of BRAF mutation-positive colorectal cancers.

Indexed as

MutationNeoplasm MetastasisColorectal NeoplasmsFemaleHumansMaleMicrosatellite InstabilityPeritoneal NeoplasmsProto-Oncogene Proteins B-rafStomach NeoplasmsBRAF protein, humanProto-Oncogene Proteins B-rafBRAF mutationcolorectal cancer

Identifiers

PMID28210747
PMCPMC5861336
OpenAlexW2590838890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.